Background/Objectives: Digital subtraction angiography (DSA) is the gold standard in the diagnosis of cerebral vasospasm, frequently observed after subarachnoid hemorrhage (SAH). However, less-invasive methods, such as computed tomography angiography (CTA), may be equally accurate. To further clarify comparability, this study evaluated the reliability of CTA in detecting cerebral vasospasm. Methods: This retrospective study included 51 patients with SAH who underwent both CTA and DSA within 24 h. The smallest diameter of the proximal cerebral arterial segments was measured in both modalities at admission and during the vasospasm period. The mean difference in diameter, the intraclass correlation coefficient (ICC) of CTA and DSA, the difference in grade of vasospasm and sensitivity, the specificity and the positive predictive value (PPV) for CTA were calculated. Results: A total of 872 arterial segments were investigated. At time of admission, arterial diameters were significantly smaller on CTA compared to DSA in all segments (−0.26 ± 0.12 mm; p < 0.05). At time of suspected vasospasm (day 9 ± 5), these differences remained significant only for the M1 segment (−0.18 ± 0.37 mm, p = 0.02), the P1 segment (−0.13 ± 0.24 mm, p = 0.04) and the basilar artery (−0.20 ± 0.37 mm, p = 0.0.04). The ICC between CTA and DSA was good (0.5–0.8). The sensitivity of CTA for predicting angiographic vasospasm was 99%, the specificity was 50% and the PPV was 92%. Conclusions: Arterial diameters measured on CTA may underestimate the arterial caliber observed in DSA; however, these absolute differences were minor. Importantly, vessel diameter alone does not fully reflect malperfusion, requiring additional imaging techniques such as CT perfusion.

Background: Eravaycline is a novel fully synthetic fluorocycline that is currently approved for complicated intra-abdominal infections. However, it is sometimes also used off-label in tertiary care centers for other infection sites as an antibiotic of last resort due to its broad spectrum of activity and efficacy against Enterobacterales, including multidrug-resistant pathogens like extended spectrum β-lactamase (ESBL) producers or carbapenem-resistant Enterobacterales, as well as all Gram-positive organisms including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin- and linezolid-resistant Enterococcus faecium (VRE). Methods: We retrospectively included a total of 78 patients from Austria and Udine who received eravacycline between April 2023 and August 2024 to evaluate the real-world efficacy of eravacycline in various infection sites and pathogens using descriptive statistics. Results: Eravacycline was most commonly used in intra-abdominal infections (44.9%), followed by pneumonia (12.8%) and infections of unknown origin (7.7%). Escherichia coli, including ESBL producers, was the most common pathogen (24.4%), followed by Enterococcus spp. (12.8%) and Klebsiella pneumoniae (12.8%). Clinical cure was achieved in 65% of patients, whereas microbiological cure was documented in 46%; source control was attained in 48.7%, and 16.7% died within 30 days. A total of 48% of patients required intensive care. Conclusions: Eravacycline represents a possible therapeutic option for a wide range of pathogens, but its use must be evaluated in the context of infection site and severity.

Background: Aneurysmal subarachnoid hemorrhage (aSAH) remains a devastating neurological condition, with patients presenting with poor-grade aSAH having a particularly limited potential for recovery. Data on outcome trajectories after microsurgical clipping in this subgroup are scarce. The objective of this study was to analyze the functional outcomes in patients with poor-grade aSAH treated with microsurgical clipping, and to identify clinical factors associated with recovery. Methods: This retrospective study included 38 patients (median age 55 years; 60.5% female) with World Federation of Neurosurgical Societies (WFNS) grades 4–5, who underwent microsurgical clipping at a single tertiary care centre between 2016 and 2023. Functional outcome was assessed using the modified Rankin Scale (mRS) at hospital discharge and 6 months follow-up, and functional outcome was analyzed in relation to clinical variables (delayed cerebral ischemia (DCI), intracerebral hemorrhage (ICH), initial seizures, the need for decompressive craniectomy) using correlation and group comparison analyses. Results: The indication for microsurgical clipping was primarily driven by the need for ICH evacuation (50%) or by aneurysm configuration (47.5%). Microsurgical aneurysm clipping was performed on the day of hemorrhage in 25 patients (65.8%), with 16 patients (42.1%) undergoing immediate surgery following direct transfer from the emergency department to the operating theatre. ICH was present in 60.5% and IVH in 92.1%. Decompressive craniectomy was performed in 42.1%. DCI occurred in 21.6% of patients. In-hospital mortality was 15.8%, increasing to 22.6% at 6 months follow-up. Good functional outcome (mRS 0–2) was observed in 10.5% of patients at discharge and improved to 25.8% at 6 months. At hospital discharge, higher mRS scores were associated with the need for immediate aneurysm repair (p = 0.04), primary decompressive craniectomy (p = 0.02), and DCI (p = 0.006). Primary decompressive craniectomy (p = 0.04), reflecting greater disease severity, and DCI (p = 0.002) remained associated with worse functional outcome at 6 months. Conclusions: In poor-grade aSAH patients undergoing microsurgical clipping, mortality remains substantial; however, functional recovery may extend beyond hospital discharge. The need for immediate surgical intervention and primary decompressive craniectomy likely reflects a particularly severe hemorrhagic burden in patients and is associated with worse early functional outcomes, whereas DCI remains an important factor in overall functional recovery.